Depo-Medrol Injection (Methylprednisolone Acetate) | Used to Reduce Inflammation & Allergic Conditions

Precaution

1. Use Only as Prescribed

Depo-Medrol is a prescription corticosteroid and should be administered by an appropriately trained healthcare professional according to the prescribed indication and route.

2. Do Not Use Intravenously

The U.S. product information specifically states that Depo-Medrol is not for intravenous use.

3. Infection Risk

Corticosteroids can reduce immune-system activity and may increase susceptibility to infections or make some infections harder to recognize. Tell your healthcare professional about any current or recent infection.

4. Diabetes and Blood Sugar

Methylprednisolone can increase blood glucose levels. People with diabetes may require closer blood-sugar monitoring during corticosteroid treatment.

5. High Blood Pressure

Corticosteroids may affect fluid and electrolyte balance and can contribute to increased blood pressure in some people. Patients with hypertension should inform their healthcare professional.

6. Stomach and Intestinal Problems

Tell your healthcare professional if you have a history of stomach ulcers, gastrointestinal bleeding, or other significant digestive problems before receiving corticosteroid treatment.

7. Eye Problems

Inform your healthcare professional about glaucoma, cataracts, or other eye conditions because prolonged or repeated corticosteroid treatment can affect the eyes.

8. Bone Health

Repeated or prolonged corticosteroid exposure may affect bone health. People with osteoporosis or other bone-related risk factors should discuss this before treatment.

Usage 

• Depo-Medrol Injection should be administered by a healthcare professional.
• The dosage depends on the medical condition, severity, treatment response, and selected route.
• The injection may be administered intramuscularly or into a joint, soft tissue, or lesion when appropriate.
• Do not self-administer the injection unless specifically trained and instructed to do so.
• The product should not be administered intravenously.
• Follow the prescribed treatment schedule and do not receive additional injections without medical advice.

Uses

1. Inflammatory Conditions

Used to reduce inflammation in selected corticosteroid-responsive conditions.

2. Rheumatic Disorders

May be used as part of treatment for certain rheumatic and inflammatory disorders.

3. Joint Inflammation

Local administration may be considered for selected inflammatory joint conditions when clinically appropriate.

4. Allergic Conditions

Corticosteroid treatment may be used for certain severe or persistent allergic conditions when indicated.

5. Soft-Tissue and Local Inflammation

May be administered into selected soft-tissue or localized inflammatory areas according to the healthcare professional's assessment.

Side Effects

Common Side Effects

• Injection-site pain or discomfort
• Temporary swelling or irritation at the injection site
• Headache
• Dizziness
• Stomach discomfort
• Increased appetite
• Difficulty sleeping
• Mood changes

Serious Side Effects

Seek prompt medical attention for:

• Severe allergic reaction
• Difficulty breathing
• Significant facial, lip, or throat swelling
• Severe infection or signs of infection
• Severe vision changes
• Significant gastrointestinal bleeding or severe abdominal pain

FAQs

1. What is Depo-Medrol Injection?

Depo-Medrol is a corticosteroid injection containing Methylprednisolone Acetate. It is used to reduce inflammation and excessive immune activity in selected medical conditions.

2. What is the generic name of Depo-Medrol?

The generic name is Methylprednisolone Acetate.

3. What type of medicine is Depo-Medrol?

It is a glucocorticoid corticosteroid medicine.

4. What strengths are available?

The U.S. Depo-Medrol product is available in 20 mg/mL, 40 mg/mL, and 80 mg/mL presentations. Availability can vary by market and product presentation.

5. Can Depo-Medrol be given intravenously?

No. The U.S. prescribing information specifically states that Depo-Medrol is not for intravenous use.

6. How is Depo-Medrol administered?

Depending on the indication, it may be administered intramuscularly or by selected local injection routes such as intra-articular, soft-tissue, or intralesional administration.

7. Does Depo-Medrol reduce inflammation?

Yes. Methylprednisolone Acetate is a glucocorticoid that produces anti-inflammatory and immunosuppressive effects.

8. Can Depo-Medrol affect blood sugar?

Yes. Corticosteroids can increase blood glucose levels, particularly in people with diabetes.

Interactions

1. Other Corticosteroids

Using multiple corticosteroid medicines may increase overall corticosteroid exposure and the risk of adverse effects.

2. Diabetes Medicines

Methylprednisolone may increase blood glucose, potentially affecting the effectiveness or dose requirements of diabetes medicines.

3. Anticoagulants

Corticosteroids may affect the response to certain anticoagulant medicines, so monitoring may be required.

4. NSAIDs

Combining corticosteroids with certain nonsteroidal anti-inflammatory drugs may increase the risk of gastrointestinal complications.

5. Vaccines

Because corticosteroids can suppress immune responses, some vaccines may require special consideration during treatment.

6. Medicines Affecting Liver Enzymes

Certain medicines can change corticosteroid metabolism and may alter methylprednisolone exposure.

7. Diuretics and Electrolyte-Affecting Medicines

Some medicines that affect fluid or electrolyte balance may require additional monitoring when used with corticosteroids.

8. Other Prescription and OTC Medicines

Tell your healthcare professional about all prescription medicines, over-the-counter medicines, vitamins, and supplements before receiving Depo-Medrol.